NCT01665222View on ClinicalTrials.gov

Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

Morphine Sulfate

Morphine Sulfate 60mg Extended-release tablets

All Listed Sponsors
lead

Ranbaxy Inc.

INDUSTRY

NCT01665222 - Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter